These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 10368698)

  • 1. Interferon plus ribavirin for chronic hepatitis C.
    Med Lett Drugs Ther; 1999 Jun; 41(1054):53-4. PubMed ID: 10368698
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost effectiveness of peginterferon alpha-2a plus ribavirin versus interferon alpha-2b plus ribavirin as initial therapy for treatment-naive chronic hepatitis C.
    Arguedas M
    Pharmacoeconomics; 2004; 22(7):477-8; author reply 478-9. PubMed ID: 15137884
    [No Abstract]   [Full Text] [Related]  

  • 3. Cost-effectiveness of peginterferon alfa-2b plus ribavirin compared to interferon alfa-2b plus ribavirin as initial treatment of chronic hepatitis C in Belgium.
    Wong J; Nevens F
    Acta Gastroenterol Belg; 2002; 65(2):110-11. PubMed ID: 12171045
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of chronic hepatitis C: interferon alpha-2b alone or in combination with ribavirin].
    Fontaine H; Pol S
    Gastroenterol Clin Biol; 1999 Apr; 23(4):541-4. PubMed ID: 10416124
    [No Abstract]   [Full Text] [Related]  

  • 5. Cost-effectiveness of interferon alfa 2b and ribavirin in the treatment of chronic hepatitis C.
    Kim WR; Poterucha JJ; Gross JB
    Hepatology; 2000 Mar; 31(3):807-8. PubMed ID: 10722315
    [No Abstract]   [Full Text] [Related]  

  • 6. [Eradication of hepatitis C virus after 3 months of interferon and ribavirin treatment in an a interferon non-responder patient with chronic hepatitis C].
    Hrycewycz N; Sandres K; Barange K; Pascal JP; Izopet J; Payen JL
    Gastroenterol Clin Biol; 2001 Nov; 25(11):1041-2. PubMed ID: 11845065
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy of combined interferon and ribavirin for treatment of hepatitis C.
    Brown JL
    Lancet; 1998 Jan; 351(9096):78-9. PubMed ID: 9439486
    [No Abstract]   [Full Text] [Related]  

  • 8. r-Interferon alfa-2b/ribavirin combined therapy followed by low-dose r-interferon alfa-2b in chronic hepatitis C interferon nonresponders.
    Perasso A; Testino G; Ansaldi F; Venturino V; Icardi GC
    Hepatology; 1999 Jan; 29(1):297-8. PubMed ID: 9935339
    [No Abstract]   [Full Text] [Related]  

  • 9. A potent antiviral effect on hepatitis C viral dynamics in serum and peripheral blood mononuclear cells during combination therapy with high-dose daily interferon alfa plus ribavirin and intravenous twice-daily treatment with interferon beta.
    Asahina Y; Izumi N; Uchihara M; Noguchi O; Tsuchiya K; Hamano K; Kanazawa N; Itakura J; Miyake S; Sakai T
    Hepatology; 2001 Aug; 34(2):377-84. PubMed ID: 11481623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ribavirin approved for hepatitis C combination treatment.
    James JS
    AIDS Treat News; 1998 Jun; (No 297):7. PubMed ID: 11365595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost effectiveness of interferon alpha2b combined with ribavirin for the treatment of chronic hepatitis C.
    Younossi ZM; Singer ME; McHutchison JG; Shermock KM
    Hepatology; 1999 Nov; 30(5):1318-24. PubMed ID: 10534357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential versus concomitant administration of ribavirin and interferon alfa-n3 in patients with chronic hepatitis C not responding to interferon alone: results of a randomized, controlled trial.
    Sostegni R; Ghisetti V; Pittaluga F; Marchiaro G; Rocca G; Borghesio E; Rizzetto M; Saracco G
    Hepatology; 1998 Aug; 28(2):341-6. PubMed ID: 9695995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Does combination therapy of chronic viral hepatitis C with interferon-alpha and ribavirin approach financial limits?].
    Steimann RU; Bode JC
    Versicherungsmedizin; 2000 Mar; 52(1):24-7. PubMed ID: 10718088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose interferon-alpha 2b plus ribavirin combination therapy for GB virus-C/hepatitis G virus infection--a study in patients with chronic hepatitis C.
    Cheng PN; Jen CM; Young KC; Chen CY; Lu SN; Wang CS; Chang TT
    Hepatogastroenterology; 2003; 50(50):449-52. PubMed ID: 12749244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-alpha-2B and ribavirin in combination for chronic hepatitis C patients not responding to interferon-alpha alone: an Italian multicenter, randomized, controlled, clinical study.
    Barbaro G; Di Lorenzo G; Soldini M; Giancaspro G; Bellomo G; Belloni G; Grisorio B; Annese M; Bacca D; Francavilla R; Rizzo G; Barbarini G
    Am J Gastroenterol; 1998 Dec; 93(12):2445-51. PubMed ID: 9860407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatitis C in Egypt, a iatrogenic epidemic].
    Vrolijk JM; Schalm SW
    Ned Tijdschr Geneeskd; 2000 Dec; 144(49):2378. PubMed ID: 11129975
    [No Abstract]   [Full Text] [Related]  

  • 17. Ribavirin approved with a big fat price.
    Falkenberg J
    Notes Undergr; 1998; (No 37):10-1. PubMed ID: 11365818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group.
    Davis GL; Esteban-Mur R; Rustgi V; Hoefs J; Gordon SC; Trepo C; Shiffman ML; Zeuzem S; Craxi A; Ling MH; Albrecht J
    N Engl J Med; 1998 Nov; 339(21):1493-9. PubMed ID: 9819447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Difficult-to-treat patient with chronic hepatitis C: a challenge in clinical practice].
    Dou XG
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jul; 17(7):486-7. PubMed ID: 19912678
    [No Abstract]   [Full Text] [Related]  

  • 20. Combination therapy for hepatitis C infection.
    Newman TB
    N Engl J Med; 1999 Apr; 340(15):1207; author reply 1208-9. PubMed ID: 10206843
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.